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ttp://dx.doi.org/10.1016/j.ajpath.2012.12.007Inﬂuenza infection is widespread in the United States and the world. Despite low mortality rates due to
infection, morbidity is common and little is known about the molecular events involved in recovery.
Inﬂuenza infection results in persistent distal lung remodeling, and the mechanism(s) involved are poorly
understood. Recently IL-22 has been found to mediate epithelial repair. We propose that IL-22 is critical
for recovery of normal lung function and architecture after inﬂuenza infection. Wild-type and IL-22/
mice were infected with inﬂuenza A PR8/34 H1N1 and were followed up for up to 21 days post infection.
IL-22 receptor was localized to the airway epithelium in naive mice but was expressed at the sites of
parenchymal lung remodeling induced by inﬂuenza infection. IL-22/ mice displayed exacerbated lung
injury compared with wild-type mice, which correlated with decreased lung function 21 days post
infection. Epithelial metaplasia was observed in wild-type mice but was not evident in IL-22/ animals
that were characterized with an increased ﬁbrotic phenotype. Gene expression analysis revealed aberrant
expression of epithelial genes involved in repair processes, among changes in several other biological
processes. These data indicate that IL-22 is required for normal lung repair after inﬂuenza infection. IL-22
represents a novel pathway involved in interstitial lung disease. (Am J Pathol 2013, 182: 1286e1296;
http://dx.doi.org/10.1016/j.ajpath.2012.12.007)Supported in part by NIH grants HL079142 (J.K.K.) and HL107380
(J.F.A.) and Parker B. Francis Foundation Fellowship (J.F.A.).Inﬂuenza viruses are highly contagious RNA viruses in the
Orthomyxoviridae family. In humans, inﬂuenza A is the most
common infectious strain of this family. In the United States,
inﬂuenza A infects 5% to 20% of the population annually, with
approximately 30,000 associated deaths. During the 2009
H1N1 pandemic, as many as 45% of young adults were sero-
positive for the virus, underscoring the broad scope of infec-
tion.1Recently, outbreaks ofmorevirulent strains havebrought
to light the serious nature of inﬂuenza A and have emphasized
the importance of understanding disease pathogenesis.
Inﬂuenza A infects epithelial cells of both the upper and
lower respiratory tract through binding of viral hemagglutinin
to sialic acid moieties on the host cell. Replication occurs
rapidly, and viral particles can be released from infected cells
as early as 24 hours after infection. Viral replication and
subsequent translation can induce endoplasmic reticulum
stress in the infected cell,2 and ultimately infected cells die
through apoptosis.3 Although the loss of infected cells can bestigative Pathology.
.beneﬁcial, because it decreases the ability of the virus to
proliferate, it leads to degeneration and desquamation of the
epithelium. This airway injury is subsequently followed by
spreading of uninfected cells, epithelial proliferation, and
mucous cell metaplasia.4 Viral clearance occurs rapidly after
infection, and in most cases recovery from viral-associated
morbidity occurs within 2 weeks of infection.
Given the high infectivity but low mortality often observed
after inﬂuenza infection, research has focused on the mecha-
nisms of viral transmission and clearance. However, recent data
suggest that inﬂuenza infection has long-term immune conse-
quences on the lung. It has been reported that some patients
recovering from inﬂuenza A outbreaks have bronchiolitis,
alveolitis, intimal thickening, and lung ﬁbrosis.5e7 In addition
to potentially causing persistent lung remodeling, inﬂuenza also
IL-22eDependent Repair after Inﬂuenzaaffects host defense. By altering T-cell function,8 Toll-like
receptor expression,9,10 and pathogen-associated molecular
recognition receptors,10 inﬂuenza increases the susceptibility of
the host to subsequent bacterial pneumonia,11 particularly to
Streptococcus pneumoniae12 and Staphylococcus aureus.8 In
mouse models, inﬂuenza has been found to cause a prolonged
period of lung remodeling and alveolitis lasting for up to 180
days post infection (d.p.i.).13e15With the increasing prevalence
of more infective and/or virulent strains of inﬂuenza, under-
standing the impact of the virus on the host epithelium and the
processes involved in lung repair are of great importance.
The repair processes in the lung include a complex inter-
action between the innate immune system and the airway
epithelium. Recent studies have identiﬁed subsets of innate
cells that are in close contact with the mucosal surfaces of the
intestine, the skin, and the lung and are required for epithelial
maintenance.16 IL-22eproducing cells represent a subset of
these cells present in the lung. IL-22 is a member of the IL-10
family and signals through the heterodimeric complex of the
IL-10R1b and Il-22Ra1 and activates STAT3. Whereas IL-
10R1b is ubiquitously expressed, IL-22Ra1 expression is
limited to the epithelial cells in digestive, skin, and respira-
tory tissues.17,18 IL-22 receptor distribution allows IL-22 to
have a direct impact on epithelial cells with little or no
interaction with immune cells. This one-way communication
allows IL-22 to act as a gatekeeper by promoting epithelial
integrity and inducing the epithelium to produce a number of
antimicrobial peptides, such as b-defensin 2 and 3, S100A7
through 9, RegIIIb and g, and lipocalin19e21
An important emerging role of IL-22 is the promotion of
epithelial repair. Although IL-22 is thought to be pathogenic
and induces psoriasis in the skin,22,23 IL-22 appears beneﬁcial
in terms of promoting resolution of injury in both the lung24,25
and intestine.26,27 It has been demonstrated that the production
of IL-22 promotes epithelial repair and cellular turnover in
a model of inﬂammatory bowel disease (IBD)27 in a STAT3-
dependentmanner.28 In the lung, our laboratory has found that
IL-22 protects the airways by increasing transepithelial
resistance and promoting bronchial epithelial cell prolifera-
tion.19 Further, IL-22 has been found to prevent apoptosis
through the production of antiapoptotic proteins, such as BclII
and Bcl2l1, in a bleomycin model of lung injury.25
Because IL-22 has been suggested to play a role in wound
repair in inﬂammatory disease, we hypothesized that IL-22
plays a critical role in regulating epithelial repair responses
during inﬂuenza infection and resolution. These data eluci-
date a novel pathway by which IL-22 is required for appro-
priate gene transcription and epithelial repair in the lung.
Materials and Methods
Mice
Speciﬁc pathogen-free mice were used in all experiments
and housed in pathogen-free conditions at Children’s
Hospital of Pittsburgh, Pennsylvania. All of the animalThe American Journal of Pathology - ajp.amjpathol.orgstudies were conducted with the approval of the University
of Pittsburgh Institutional Animal Care and Use Committee.
Six- to 8-week-old wild-type (WT) C57BL/6 mice were
purchased from Taconic (Germantown, NY). IL-22/ were
bred in house as previously described.8 All of the studies
were performed on age-matched male mice.
Inﬂuenza A PR/8/34 H1N1 Infection
Inﬂuenza A PR/8/34 H1N1 was propagated in chicken eggs
as described previously.29 Mice were infected with 100
plaque-forming units of inﬂuenza A PR/8/34 H1N1 (in
40 mL of sterile PBS) from a frozen stock or control PBS by
oropharyngeal aspiration. Infected mice were incubated for
10 or 21 days, at which time mice lungs were harvested.
Viral burden was determined by quantitative real-time RT-
PCR on lung RNA for viral matrix protein as described
previously.30
Analysis of Lung Inﬂammation and Lung Injury
At 10 days, bronchoalveolar lavage (BAL) ﬂuid was
collected as previously described.31 Tracheas were exposed
and cannulated. The BAL ﬂuid was collected in 10 1-mL
aliquots of sterile PBS supplemented with 0.6 mmol/L
EDTA. The ﬁrst aliquot was centrifuged for 10 minutes at
500  g, and the supernatant was collected for protein
analysis and lactate dehydrogenase (LDH) activity. The cell
pellet was resuspended and combined with the remaining
aliquots. Aliquots were combined and centrifuged for 10
minutes at 500  g. Cells were resuspended in 1 mL of
PBS-EDTA and counted. A total of 1  105 cells were spun
onto a glass slide and stained for differential counting.
To measure lung injury, total protein in the ﬁrst milliliter of
BAL ﬂuid was measured using the BCA Protein Assay Kit
(Pierce Chemical, Rockford, IL). LDH activity was measured
using the LDH assay (Sigma-Aldrich, St. Louis, MO). Both
assays were performed in a 96-well plate for 30 minutes
according to themanufacturer’s instructions andanalyzedusing
the Benchmark Plus plate reader (Bio-Rad, Hercules, CA).
Histologic Analysis
Animals were sacriﬁced by intraperitoneal injection of
0.9 mL/kg of ketamine and xylazine followed by exsan-
guination through the renal artery. After exposing the chest
cavity, the right main bronchus was sutured at the base of
the main stem, and the right lung was excised and placed in
Trizol for RNA extraction. The left lung was inﬂated with
10% neutral-buffered formalin (Sigma Chemical Co, St
Louis, MO) at a pressure of 25 cm H2O for 10 minutes,
removed from the animal, and placed in fresh 10% neutral-
buffered formalin for 24 hours before processing and
parafﬁn embedding. For histologic analysis, 5 mm sections
were cut and stained with H&E. Histologic scoring was
performed by a pathologist reviewer (D.A.P.) on blinded1287
Pociask et allung sections. Lung injury induced by inﬂuenza was
assessed by a numerical scoring scale from 0 to 3
(increasing in severity). Regions of lung injury in sections
were scored for the extent of intimal thickening, alveolitis,
and the presence of proteinaceous material in the alveolar
space. Epithelial denudation was quantiﬁed by counting the
number of denuded airways per section.
Immunohistochemistry for IL-22Ra1
Lung sections were deparafﬁnized in xylene (3  10
minutes) and rehydrated through sequential washings of
100%, 95%, and 75% ethanol (2  10 minutes). Antigen
retrieval was performed by boiling for 10 minutes in
10 mmol/L citrate buffer followed by 30 minutes at room
temperature. After peroxidase blocking (3% hydrogen
peroxide for 10 minutes), slides were blocked following the
Vectastat ABC blocking protocol for Rat IgG (Vector
Laboratories, Burlingame, CA). IL-22Ra1 was visualized
using Rat anti-mouse IL-22Ra1 (clone 496514; R&D
Systems, Minneapolis, MN) at a dilution of 1:100.
Picrosirius Red Staining and Collagen Quantitation
After deparafﬁnization and rehydration, nuclei were stained
with Wiegert’s hematoxylin for 10 minutes followed by
a 10-minute wash in running tap water. Collagen was
stained in picrosirius red for 1 hour followed by two washes
in acidiﬁed water. Slides were dehydrated, cleared in
xylene, and mounted.
Collagen was quantiﬁed microscopically. To be considered
for analysis, eachﬁeld had tobe>90%parenchyma. Fiveﬁelds
of inﬂuenza affected (altered epithelial morphologic features
and inﬂammation) and ﬁve ﬁelds of unaffected lung (normal
alveolar pathologic features) were identiﬁed at 200 magni-
ﬁcation. After identiﬁcation under bright ﬁeld, images were
taken under polarized light. NIS Elements software version 3.2
(Nikon Instruments,Melville, NY) was used to calculate tissue
volume density (TVD) deﬁned as the percentage of each
microscopic ﬁeld that is lung tissue and the percentage of each
tissue-containing ﬁeld that is collagen. Values for all ﬁelds
were averaged to yield a single TVD per animal. TVD valuesFigure 1 A and B: IL-22Ra1 is distributed on epithelial cells of the large an
formalin-ﬁxed, parafﬁn-embedded lung tissue. These representative photomicrogra
no staining in the lung parenchyma. C: Control without primary antibody. Origin
1288per animal were then averaged to yield a group average.
Unaffected areaswere used as a negative control for eachgroup
and showed no differences between groups.
RNA Isolation and Microarray Analysis of Gene
Expression
RNA was isolated from the right lung using Agilent
Absolutely RNA kit (Agilent, Foster City, CA). RNA
quality was determined using a Nanodrop-1000 spectro-
photometer (Nanodrop Technologies, Wilmington, DE) and
Agilent 2100 Bioanalyzer (Agilent, Foster City, CA). All
microarray analysis was performed at the University of
Pittsburgh Genomics and Proteomics Core Laboratory using
the Illumina mouse WG6 array (Illumina, San Diego, CA)
according to the manufacturer protocol.
Microarray data obtained from whole lung RNA were
analyzed by the J5 score threshold as previously pub-
lished.32 The threshold value is the absolute value of the J5
score that a gene must be above to be considered differen-
tially expressed. The J5 score is calculated by dividing the
mean difference between group 1 and 2 by the averaged
absolute mean difference for all genes in the data set. Its
sign indicates the directionality. For example, positive J5
means overexpressed and negative means underexpressed.
Microarray data are deposited at the Gene Expression
Omnibus (http://www.ncbi.nlm.nih.gov/geo; accession num-
ber GSE41549).
To develop functional proﬁles of the microarray data,
gene ontology analysis was performed using Onto-Express,
and biological pathways were identiﬁed using Pathway-
Express,33,34 both of which are parts of Onto-Tools version 3
(http://vortex.cs.wayne.edu/projects.htm; Detroit, MI; regis-
tration required).35 Pathway-level impact analysis was imple-
mented as described by Draghici et al,33 and the results are
summarized as impact score and P values.
Lung Function Testing
Pulmonary function was measured by the forced oscillation
technique using the FlexiVent apparatus (Scireq,Montreal, QC,
Canada) as previously described.36 Mice were tracheotomizedd small airways of naive C57BL/6 mice. IL-22Ra1 was immune-localized in
phs demonstrate the IL-22Ra1 is localized to the airway epithelial cells with
al magniﬁcation: 100 (A); 400 (B).
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Figure 2 IL-22/ mice have greater injury and altered inﬂammatory
response to inﬂuenza infection. BAL ﬂuid was collected and analyzed from
inﬂuenza infectedmice 10 d.p.i.A: Total protein wasmeasured using the BCA
protein assay kit. P < 0.01. B: Cell cytotoxicity was detected by measuring
lactate dehydrogenase. P < 0.05. Each circle and square in A and B repre-
sents an individualmouse. C: Total cell counts in BAL ﬂuid.D: Differential cell
counts preformed on BAL cells. Results are representative of two separate
experiments, and values are the means  SD (nZ 6). *P < 0.05.
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Figure 4 IL-22/ mice have greater morbidity and altered lung
function during recovery from inﬂuenza infection. WT (nZ 7) and IL-22/
(n Z 8) mice were infected with inﬂuenza for 21 days. A: Weight loss
shown as a percentage of the original starting weight. B: Airway resistance.
C: Lung compliance measured by pressure-volume analysis. D: Hysteresis
(area) of the pressure volume curve. *P < 0.05 versus naive control; **P <
0.05 versus WT mice.
IL-22eDependent Repair after Inﬂuenzawith an18-gauge cannulawhile under anesthesiawith 90mg/kg
of pentobarbital-sodium. Ventilation was conducted at 200
breaths per minute at a tidal volume of 0.2 mL with a positive
end-expiratory pressure of 3 cmH2O.Multiple linear regression
was used to ﬁt pressure and volumemeasurements to themodelFigure 3 IL-22/ mice display altered airway epithelial activation
after inﬂuenza infection. Lungs from mice infected with inﬂuenza for 10
days were inﬂated to 25 cm H2O by intratracheal installation of 10%
neutral buffered formalin (n Z 7). Lung sections were stained with
H&E. A and C: WT, C57BL/6 mice demonstrated inﬂammation and
regenerative epithelium with mucous cell metaplasia (black arrows)
within the airways. B and D: IL-22/ mice had reduced epithelial
regeneration with ﬂattened epithelial cells (white arrows) and in some
cases denuded airway epithelium. Original magniﬁcation: 100 (A and
B); 400 (C and D).
The American Journal of Pathology - ajp.amjpathol.orgof linear motion of the lung. Model ﬁts <0.80 were excluded.
Baseline measurements of airway resistance, tissue resistance,
and tissue elastance were made. In addition, pressure-volume
analysis of the lung was conducted using stepwise volume
inﬂation and deﬂation of the lung to a maximum pressure of
30 cm H2O. The pressure-volume data were used to calculate
static lung compliance.Statistical Analysis
All data are represented as the mean  SEM. Signiﬁcance
was determined using either an unpaired t-test when
comparing two groups or a one-way analysis of variance
with Bonferroni adjustment when comparing multiple
groups. All statistics were calculated using computer soft-
ware (GraphPad Prism version 4, San Diego, CA).Results
Previously, we have reported that IL-22 signals via STAT3
in mouse tracheal epithelial cultures and human bronchial
epithelial cells and induces genes that encode antimicrobial
proteins and cell cycle genes.19 Although these data suggest
IL-22 has an impact on the airway epithelium, little is
known about the distribution of the IL-22 receptor in vivo.
To examine this, immunohistochemical analysis was per-
formed in the lungs of naive C57BL/6 mice for high-afﬁnity
IL-22Ra1. IL-22Ra1 was distributed on epithelial cells of
the large and small airways with no identiﬁable staining in
the lung parenchyma or endothelium in naive mice
(Figure 1). This receptor distribution suggests IL-22 inter-
acts mainly with the bronchial epithelial cells in the absence
of lung injury.1289
Figure 5 Inﬂuenza induces alveolar metaplasia in WT mice but not
IL-22/ mice. WT (nZ 7) and IL-22/ (nZ 8) mice were infected with
inﬂuenza for 21 days. A: Representative histologic stain shows WT mice have
organized epithelial regeneration occurring in the alveolar spaces. C:
Epithelial cells appear metaplastic. Histologic stains in IL-22/ mice where
epithelial cells are less organized in appearance (B) and epithelium have
amore injuredﬁbrotic appearancewith no evidence ofmetaplasia (D). E: Lung
injury scoring for intimal thickening, alveolitis, and the presence of protein-
aceous material in the alveolar space (nZ 7 and 8, respectively). *P < 0.05
versus WT mice. Original magniﬁcation, 100 (A and B); 400 (C and D)
Figure 6 IL-22/ mice have greater collagen deposition after inﬂu-
enza infection. Sections were stained for picrosirius red and analyzed by
bright ﬁeld microscopy. Areas undergoing injury and repair were chosen
and imaged under polarized light. IL-22/ mice (A) had more collagen in
affected areas than WT mice (B). C: Digital quantiﬁcation of staining (nZ 6).
White (collagen) versus black (area) was quantiﬁed as percent area.
Pociask et alTo investigate the functional importance of IL-22 in the
airways after viral injury, IL-22/ mice were challenged with
a sublethal dose of 100 plaque-forming units of inﬂuenza A PR/
8/34 H1N1.30 There were no differences in viral clearance
between C57BL/6 and IL-22/ mice because the viral matrix
protein was undetectable by quantitative real-time PCR in both
strains ofmice at 10 days (data not shown).Because viral burden
is relatively low 10 d.p.i., we measured virus levels on day 7.
Relative expression of inﬂuenza matrix protein was 1.00 
0.76 inC57BL/6mice comparedwith 1.34 0.23 in IL-22/
mice (nZ 4), further conﬁrming no differences in viral load.
Lung injury was assed 10 d.p.i.by measuring total protein and
LDH, a marker of cell lysis, in BAL ﬂuid. IL-22/ mice
demonstrated more severe injury and greater lung edema
because they both had signiﬁcantly higher LDH levels and
more total protein in the BAL ﬂuid (Figure 2, A and B) than
WT controls. These differences in lung injury did not corre-
spond with weight loss because there were no signiﬁcant
differences in weight loss when comparing WT mice and
IL-22/ mice at this time point (data not shown).1290Although IL-22Ra1 may not be found on inﬂammatory
cells, IL-22 has been shown to have immunosuppressive
effects.37 To characterize the inﬂammatory role of IL-22
during inﬂuenza infection, total and differential cell counts
were performed on BAL ﬂuid. There were no differences
in total cell counts between WT and IL-22/ mice
(Figure 2C). Further, whereas both IL-22/ and WT
mice had similar percentages of macrophages and poly-
morphonuclear cells, IL-22/ had signiﬁcantly greater
numbers of lymphocytes (Figure 2D). These data indicate
that the loss of IL-22 results in worsened lung injury,
despite small changes in lung inﬂammation and no differ-
ences in viral clearance.
Inﬂuenza infection is known to induce the development
of epithelial hyperplasia and mucous metaplasia during
recovery from injury.4 Histopathologic analysis at 10 d.p.i.
revealed stark differences between the two strains. IL-22/ajp.amjpathol.org - The American Journal of Pathology
Figure 7 IL-22Ra1 is found in areas of epithelial metaplasia after
inﬂuenza infection. Representative immunohistochemical staining for IL-
22Ra1 reveals expression of the receptor in the alveoli 21di. A and B:
Images demonstrate strong staining of the alveolar epithelial cells. C: Type
II cells adjacent to the injury also demonstrate receptor staining. D: IgG
control. Original magniﬁcation: 100 (A); 400 (B and C).
IL-22eDependent Repair after Inﬂuenzamice demonstrated epithelial degeneration with ﬂattened
airway cells and little to no airway mucous cell metaplasia
and hyperplasia in contrast to the typical regeneration seen
in the WT controls (Figure 3, AeD). Denudation of the
airways was not observed in C57BL/6 mice but was present
in IL-22/ animals. Quantiﬁcation of epithelial denudation
revealed its presence in 2.29  0.28 airways per section in
IL-22/ mice (n Z 7). These data suggest that IL-22 is
required for airway epithelial homeostasis and repair after
inﬂuenza infection. Because IL-22Ra1 is expressed on the
epithelium of naive mice, we examined the epithelium of
naive C57BL/6 and IL-22/ mice to determine whether
IL-22 regulates lung homeostasis. We did not ﬁnd structuralTable 1 Top 20 Differentially Regulated and Identiﬁed Non-mitochon
Gene
Lactotransferrin (Ltf )
Heat shock protein 8 (Hspa8)
Thymosin, beta 4, X chromosome (Tmsb4x)
Glutathione peroxidase 1 (Gpx1)
PRED: similar to MHC class II antigen beta chain (LOC641240)
Procollagen, type IV, alpha 1 (Col4a1)
Ribosomal protein L27 (Rpl27)
Glutathione S-transferase omega 1 (Gsto1)
Surfactant associated protein D (Sftpd )
PRED: similar to Ig kappa chain V-V region L7 precursor (LOC636875)
CD74 antigen (Cd74), transcript variant 1
PRED: similar to ribosomal protein L3 (LOC433745)
Eukaryotic translation initiation factor 3, subunit F (Eif3f )
Cytochrome P450, family 2, subfamily f, polypeptide 2 (Cyp2f2)
Coagulation factor II (thrombin) receptor (F2r)
Ribosomal protein L35 (Rpl35)
Histocompatibility 2, class II antigen A, beta 1 (H2-Ab1)
Palate, lung, and nasal epithelium associated (Plunc)
Caveolin 1, caveolae protein (Cav1)
Ribosomal protein S5 (Rps5)
The American Journal of Pathology - ajp.amjpathol.orgabnormalities in the large or small airways of IL-22/ mice
(Supplemental Figure S1). These data indicate that IL-22 is
likely to play a critical role in epithelial repair.
Although inﬂuenza virus is typically cleared 7 d.p.i., it has
been found that inﬂuenza A PR/8/34 H1N1 causes long-term
changes (up to 180 d.p.i.) in the lung parenchyma, with
persistent inﬂammation and patches ofmetaplastic epithelium
in the lung parenchyma.13e15 Given the phenotypic differ-
ences seen at 10 d.p.i., we next wished to determine whether
mice lacking IL-22 recovered from inﬂuenza infection similar
to controls. Mice were challenged with inﬂuenza A PR/8/34
H1N1, and theirweightwas followed for 21 days as ameasure
of morbidity. Although there were no differences in weight at
the early time points, IL-22/ had a signiﬁcantly poorer
weight recovery (P< 0.0001) compared with C57BL/6 mice
(84.42%  2.73% versus 100.52%  10.68%) (Figure 4A).
Neither WT nor IL-22/mice had detectable inﬂuenza virus
gene expression 21 d.p.i., indicating no defect in viral clear-
ance (data not shown). To determine whether IL-22/ mice
had functional differences after inﬂuenza infection, lung
mechanics were measured in mechanically vented mice 21
d.p.i. Mice infected with inﬂuenza had no signiﬁcant differ-
ences in baseline airway resistance compared with naive
controls (Figure 4B). Consistent with the injury phenotypes
seen, both ﬂu (0.063  0.0128 cm H2O/mL/second) and
IL-22/ mice (0.057  0.0104 cm H2O/mL/second) had
signiﬁcantly decreased compliance (P < 0.001) compared
with naive controls (0.083  0.0059 cm H2O/mL/second)
(Figure 4C). Further, IL-22/ mice had signiﬁcantly
increased hysteresis (3.83  0.515 mL/cm H2O) compared
with both the naive (2.86 1.025 mL/cm H2O) and WT plus
ﬂu (3.033  0.345 mL/cm H2O) groups (Figure 4D).
Decreased compliance and increased hysteresis indicate
a stiffening of the lung.drial Genes between IL-22/- and C57BL/6 (WT) Mice 21 d.p.i.
Accession no. J5 score
NM_008522.3 187.302
NM_031165.4 103.969
NM_021278.2 97.382
NM_008160.5 70.805
XM_918601.3 69.453
NM_009931.1 68.738
NM_011289.1 68.074
NM_010362.2 66.784
NM_009160.1 65.692
XM_992953.1 63.438
NM_001042605.1 63.417
XM_001475733.1 62.876
NM_025344.1 61.929
NM_007817.2 60.559
NM_010169.3 59.797
NM_025592.3 57.276
NM_207105.2 56.000
NM_011126.2 55.965
NM_007616.3 55.597
NM_009095.1 55.142
1291
translation
oxidation reduction
apoptosis
immune response
electron transport chain
signal transduction
antigen processing and presentation
proton transport
G-protein coupled receptor protein signaling pathway
ATP synthesis coupled proton transport
lung development
response to oxidant stress
antigen processing and presentation of exogenous protein- MHC …
chaperone cofactor-dependant protein folding
antigen processing and presentation of peptide or polysaccaride-…
antigen processing and presentation of peptide antigen via MHC …
alveolus development
regulation of liquid surface tension
Figure 8 Functional analysis of gene array
data comparing WT and IL-22/ mice. Functional
annotation analysis (Onto-Tools) was performed
on genes found to be signiﬁcantly different
(increased or decreased) at a J5 threshold >5 (n
Z 4). The graph represents the 18 processes
found to be signiﬁcantly different (P < 0.01).
Pociask et alLung stiffening may be due to decreased epithelial repair
and subsequent collagen deposition. Consistent with these
data, histopathologic analysis revealed at 21 d.p.i. WT mice
had patchy inﬂammation and developed alveolar metaplasia
with activated epithelium (Figure 5, A and C). In contrast,
IL-22/ mice displayed regions lacking in this metaplasia
(Figure 5, B and D). Instead, they developed a diffuse
inﬂammation and diffuse alveolar injury with little meta-
plasia evident. Lung injury was measured by examining the
extent of intimal thickening, alveolitis, and the presence of
proteinaceous material in the alveolar space. IL-22/ mice
had signiﬁcantly higher intimal thickening and proteina-
ceous accumulation compared with WT mice (Figure 5E).
To determine whether there were differences in WT and
IL-22/ mice regarding collagen deposition, picrosirius red
staining was performed on tissues 21 d.p.i. Collagen was
visualized using polarized light, and images were quantiﬁed
for percentage of collagen per 200 ﬁeld. Histologic anal-
ysis revealed IL-22/ mice had increased collagen depo-
sition compared with WT controls (Figure 6, A and B).
Digital quantiﬁcation conﬁrmed that IL-22/ had a signiﬁ-
cantly greater percentage of collagen staining in the lung
parenchyma (Figure 6C).
These ﬁndings in the lung parenchyma were interesting
because we found IL-22 receptor only in the airways ofTable 2 Differentially Regulated Epithelial Genes
Lung epithelial genes Accession no. J5 score
Surfactant associated protein B
(Sftpb)
NM_147779.1 32.346
Surfactant associated protein C
(Sftpc)
NM_011359.1 19.118
Surfactant associated protein D
(Sftpd )
NM_009160.1 65.692
Surfactant associated protein A1
(Sftpa1)
NM_023134.4 47.018
Secretoglobin, family 1A, member 1
(uteroglobin) (Scgb1a1)
NM_011681.2 51.336
1292naive mice. If IL-22 is directly involved in alveolar repair,
the receptor must be up-regulated in these cells after injury.
To test our hypothesis, we stained for the IL-22Ra1 in the
lung from C57BL/6 mice 21 after inﬂuenza infection.
Results indicate that although the receptor is not normally
found in the parenchyma (Figure 1), it is expressed in the
repairing alveoli after injury (Figure 7, A and B), including
type II cells adjacent to areas of remodeling (Figure 7C).
Antibody control revealed speciﬁc epithelial cell staining
because only airspace debris stained positive (Figure 7D).
IL-22Ra1 expression was also increased in the areas of lung
injury in IL-22/ mice (data not shown). These novel
ﬁndings suggest IL-22Ra1 can be up-regulated at sites of
injury and further emphasize the importance of this potent
cytokine in pulmonary epithelial repair.
These data suggest that IL-22 is required for proper
epithelial maintenance and repair in both the airways and
parenchyma. To better deﬁne the cellular and molecular
processes involved in epithelial remodeling 21 d.p.i.,
genome-wide mRNA expression proﬁling was performed.
RNA was screened by oligonucleotide arrays. Bioinformatic
analysis using a threshold of >5 identiﬁed 1205 differen-
tially expressed genes between inﬂuenza infected IL-22/
mice and WT mice. Of these, 643 were transcriptionally
up-regulated, and 562 genes were negatively regulated.
Table 1 lists the top 20 differentially regulated genes.
Gene ontology analysis of these differentially regulated
genes revealed enrichment of genes associated with trans-
lation, oxidation reduction, apoptosis, the immune response,
and antigen processing and presentation (Figure 8). Further,
genes involved in lung development, alveolus development,Table 3 Differentially Regulated Basement Membrane Genes
Basement membrane genes Accession no. J5 score
Procollagen, type IV, alpha 1 (Col4a1) NM_009931.1 68.739
Collagen, type IV, alpha 2 (Col4a2) NM_009932.2 29.891
Procollagen, type VI, alpha 3 (Col6a3) NM_009935.1 8.381
Procollagen, type VI, alpha 1 (Col6a1) NM_009933.2 7.574
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Figure 9 Pathway analysis of genes found to
be signiﬁcantly different in IL-22/ mice 21
d.p.i. Pathway analysis was performed using
Pathway Express (Onto-Tools) on genes found to
be signiﬁcantly different (increased or decreased)
at a J5 threshold >5 (n Z 4). The graph repre-
sents the impact factor of the top 20 signiﬁcantly
affected pathways.
IL-22eDependent Repair after Inﬂuenzaand regulation of surface tension were also differentially
regulated. Of the epithelial genes, surfactant protein D and
surfactant protein A1 were down-regulated (65.69 and
47.02), and surfactant proteins B and C were up-regulated
(19.11 and 32.35) in IL-22/ mice versus controls.
Tables 2 and 3 list the relevant epithelial and basement
membrane markers. These data suggest differences in
epithelial regeneration between IL-22/ and WT mice.
To identify deregulated KEGG pathways, Onto-Tools
Pathway Express analysis was performed on all genes
with a threshold difference of >5. Figure 9 shows the
signiﬁcantly affected pathways. The top three pathways
ranked by impact factor were leukocyte adhesion mole-
cules (impact factor Z 129.19, P Z 1.94  105),
cellular adhesion molecules (impact factor Z 93.57, P Z
9.48  106), and antigen processing (impact factor Z
31.06, P Z 4.44  107). In these pathways, the genes
that are up-regulated are all involved in cell-cell inter-
action and cellular adhesion. These data support the
pathologic data and suggest that mice lacking IL-22 have
increased inﬂammation and slower wound healing after
H1N1 infection.
Discussion
Inﬂuenza viruses are among the most common cause of
respiratory disease. Although inﬂuenza generally has a low
mortality, it can induce acute respiratory distress syndrome38
associated with diffuse alveolar damage39,40 and even
pulmonary ﬁbrosis.13 With the recent H1N1 pandemic and
the outbreaks of more virulent strains, it is increasingly
important to understand the injury caused by inﬂuenza
infection and the mechanisms involved in pulmonary repair
and recovery after infection. In this study, we demonstrate the
importance of IL-22 in the resolution and repair of lung injuryThe American Journal of Pathology - ajp.amjpathol.orgafter inﬂuenza-induced pneumonia. We found that IL-22Ra1
is expressed in the airways but not the parenchyma of naive
mice. Through the use of IL-22/ mice, we demonstrated
that IL-22 promotes epithelial repair in the airways after
infection because IL-22/ mice had signiﬁcantly more
damage and less repair at 10 days. Interestingly, by 21 d.p.i.,
we found that IL-22Ra1 was expressed in the parenchyma in
areas of epithelial metaplasia in WT mice, suggesting a role
for IL-22 in parenchymal repair. This observation was sup-
ported by histopathologic evidence in which IL-22/ had
less epithelial repair in the parenchyma, which coincided
with greater collagen deposition and signiﬁcantly increased
lung stiffness as measured by FlexiVent. Further, microarray
analysis demonstrated differences in the regulation of
epithelial genes. These data demonstrated that IL-22 is crit-
ical in the initial response to airway injury because IL-22/
mice had increased airway epithelial injury.
IL-22 was initially thought to be a signature TH17 cyto-
kine. However, recent investigations have found that IL-22
is produced by multiple T-cell subsets during both innate
and adaptive immune responses. In the lung, IL-22 is
produced by TH17 cells,
19 gd T cells,41 innate lymphoid
cells,42 and natural killer T cells.43,44 In response to inﬂu-
enza, IL-22 is produced by natural killer cells,44 invariant
natural killer cells, T cells,45 and CD8T (Tc)17 effector
cells.46
Although a number of inﬂammatory cells produce IL-22,
its mode of action is limited because of its receptor distri-
bution. IL-22 signals through the combination of the IL-10R2
and IL-22Ra1. Although IL-10R2 is widely expressed,
IL-22Ra1 expression is limited predominantly to epithelial
cells of the skin,22 lung,25,44 and intestine,47 as well as being
basally expressed in the pancreas48 and liver.49 In this study,
we found that IL-22Ra1 is produced by both Clara and cili-
ated cells of the airway epithelium of naive mice but is not1293
Pociask et alconstitutively produced by epithelial cells in the parenchyma.
This expression pattern suggests the primary role of IL-22 is
in the protection and maintenance of the airway epithelium,
which is the primary target of the inﬂuenza virus. Through
the use of IL-22/ mice, we were able to demonstrate the
importance of IL-22 in airway repair because IL-22/ mice
had greater injury markers and limited epithelial repair with
limited airway cell metaplasia as observed by histologic
analysis.
Because inﬂuenza targets airway epithelial cells where it
induces endoplasmic reticulum stress2 and apoptosis,3 the
mode of protection for IL-22 can be either antiviral or directly
protecting the epithelium. IL-22 is induced in response to both
bacterial19 and viral44,45 infections. IL-22 is integral in the
clearance of various bacterial infections; however, in the case
of viral infections, the role of IL-22 is less obvious. IL-22 is
up-regulated in hepatitis B50,51 and hepatitis C52 infection but
has not been found to have any antiviral properties. Similarly,
in the lung, although IL-22eproducing cells are found in
response to inﬂuenza infection, we and others have found that
IL-22 does not affect viral titer.44,45 These observations
suggest that the beneﬁts of IL-22 in inﬂuenza infection are not
due to lessened viral burden but due to direct interaction with
epithelial cell repair.
Although IL-22 appears important in promoting airway
repair, airway epithelial cells appeared similar in WT and
IL-22/ mice by 21 d.p.i. This is not surprising because
a number of factors, such as hepatocyte growth factor53 and
IL-33,18,54 are known to play a role in airway repair. More
surprising were ﬁndings that IL-22 may have a role in
parenchymal repair after infection. Previously, others have
reported that inﬂuenza infection leads to an acute respiratory
distress syndromeelike disease in mice,55 characterized
alveolar destruction similar to diffuse alveolar damage,15,55
and even ﬁbrotic changes.13e15 In our model, we found WT
C57BL/6 mice had alveolar injury and areas of repairing
alveoli characterized by areas of epithelial metaplasia or
“activated” epithelial cells. Intriguingly the repairing
parenchyma also stained for the IL-22Ra1. These data were
in contrast to naive parenchyma in which the IL-22Ra1 was
not detected. Previously increased induction of IL-22Ra1
has been associated with psoriasis,22,56 and increased
receptor levels have been found in patients with Crohn’s
disease57 and in mouse models of ConA hepatitis.49 IL-
22Ra1 expression was also elevated in regions of lung
injury in IL-22/ mice. This is not surprising because IL-
22Ra1 is used by additional ligands IL-20 and IL-24, the
role of which is not currently known in the lung.
The ﬁnding that IL-22Ra1 was induced after parenchymal
injury suggests that IL-22 is an important cytokine in alveolar
epithelial repair. A number of studies have demonstrated the
importance of IL-22 after parenchymal injury. Simonian
et al40 demonstrated that mice lacking IL-22eproducing gd
T cells developed amore severeﬁbrosis after chronic bacterial
infection. Further, although IL-22 was not found to reduce
ﬁbrosis, it protected epithelial cells from bleomycin-induced1294apoptosis.25 In our study, we found that IL-22/ mice had
less activated epithelium and poorly organized repair. The
reduced epithelial repair leads to increased collagen deposi-
tion and greater lung stiffness. Consistent with this, functional
analysis of gene array data demonstrated that genes in path-
ways regulating surface tension and genes involved in
alveolar development were signiﬁcantly different in IL-22/
mice. Secretoglobin family 1A, member 1 (Scgb1a1), which
is speciﬁc for Clara cells,58 and caveolin 1 (Cav1), which is an
alveolar type I and endothelial cell marker,59 were decreased,
whereas surfactant protein C (Sftpc), a type II cell marker,60
was increased. Decreased alveolar type I cell markers and
increased type II markers suggest less cell differentiation in
IL-22/ mice because of decreased repair and a persistent
injured state.
Most inﬂuenza A infections are not fatal, and the symp-
toms of inﬂuenza infection last only a few days. Conse-
quently, the more chronic effects of inﬂuenza infection tend
to be overlooked. Our laboratory and others have found that
inﬂuenza infection enhances the susceptibility to secondary
bacterial8,12 and ﬁbrotic13,14 challenges. These studies
demonstrate the importance of understanding the more long-
term consequences of inﬂuenza challenge. In the work
presented here, we report that IL-22 is an important cytokine
in pulmonary epithelial repair after inﬂuenza infection. The
therapeutic potential of manipulating IL-22 and its receptor
offers a target to promote epithelial recovery after inﬂuenza
infection and ultimately may improve patient outcome in
regard to secondary challenges.
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